{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:13:50Z","timestamp":1772133230839,"version":"3.50.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188720","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T13:42:02Z","timestamp":1512654122000},"page":"e0188720","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis\u2014A nationwide cohort study"],"prefix":"10.1371","volume":"12","author":[{"given":"Ting-Tse","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cho-Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Tsun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Feng","family":"Yeih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7505-6429","authenticated-orcid":true,"given":"Lian-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"issue":"6937","key":"ref1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"GS Firestein","year":"2003","journal-title":"Nature"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjmed.2008.06.011","article-title":"Cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"121","author":"SE Gabriel","year":"2008","journal-title":"Am J Med"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"JA Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"24","key":"ref4","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"N Sattar","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3899\/jrheum.100979","article-title":"The influence of rheumatoid arthritis disease characteristics on heart failure","volume":"38","author":"E Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.autrev.2016.07.026","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers","volume":"15","author":"R Lopez-Mejias","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.bor.0000158150.57154.f9","article-title":"Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions","volume":"17","author":"N Sattar","year":"2005","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"WG Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"20","key":"ref9","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"MA Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1161\/01.CIR.95.12.2643","article-title":"Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial","volume":"95","author":"MA Pfeffer","year":"1997","journal-title":"Circulation"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9149(00)01209-1","article-title":"Effect of angiotensin-converting enzyme inhibitor on cardiopulmonary baroreflex sensitivity in patients with acute myocardial infarction","volume":"86","author":"M Hikosaka","year":"2000","journal-title":"Am J Cardiol"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"S Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.22053","article-title":"Insulin resistance and impaired beta cell function in rheumatoid arthritis","volume":"54","author":"PH Dessein","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9386","key":"ref14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"S Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"R Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"MJ Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"ref17","first-page":"2095","article-title":"Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis","volume":"32","author":"C Tikiz","year":"2005","journal-title":"J Rheumatol"},{"issue":"17","key":"ref18","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.107.734384","article-title":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis","volume":"117","author":"AJ Flammer","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.2015.96","article-title":"Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis","volume":"88","author":"TT Lin","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/biomet\/87.3.706","article-title":"The role of the propensity score in estimating dose-response functions","volume":"87","author":"G Imbens","year":"2000","journal-title":"Biometrika"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","article-title":"Propensity score methods for confounding control in nonexperimental research","volume":"6","author":"MA Brookhart","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/jep.12254","article-title":"Combining propensity score-based stratification and weighting to improve causal inference in the evaluation of health care interventions","volume":"20","author":"A Linden","year":"2014","journal-title":"J Eval Clin Pract"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"MY Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/rheumatology\/ken159","article-title":"Hypertension in rheumatoid arthritis","volume":"47","author":"VF Panoulas","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"9438","key":"ref25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"S Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1093\/ajh\/7.7.7S","article-title":"Established risk factors and coronary artery disease: the Framingham Study","volume":"7","author":"PW Wilson","year":"1994","journal-title":"Am J Hypertens"},{"issue":"10022","key":"ref27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"D Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0002-8703(96)90556-6","article-title":"Links between hypertension and myocardial infarction","volume":"132","author":"H Rakugi","year":"1996","journal-title":"Am Heart J"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08037051.2014.868629","article-title":"2013 ESH\/ESC Practice Guidelines for the Management of Arterial Hypertension","volume":"23","author":"G Mancia","year":"2014","journal-title":"Blood Press"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"P Libby","year":"2008","journal-title":"Am J Med"},{"key":"ref31","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"1","author":"PE Lazzerini","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"C Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"A Benigni","year":"2010","journal-title":"EMBO Mol Med"},{"issue":"23","key":"ref34","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"IB McInnes","year":"2011","journal-title":"N Engl J Med"},{"issue":"8390","key":"ref35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(84)91821-X","article-title":"Captopril: a new treatment for rheumatoid arthritis?","volume":"1","author":"MF Martin","year":"1984","journal-title":"Lancet"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.22335","article-title":"Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis","volume":"56","author":"A Price","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1\u20133","key":"ref37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejphar.2012.10.024","article-title":"Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats","volume":"698","author":"R Refaat","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/ard.2007.082917","article-title":"Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis","volume":"67","author":"ME Perry","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"9215","key":"ref39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"MD Flather","year":"2000","journal-title":"Lancet"},{"issue":"9395","key":"ref40","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"F Turnbull","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"A Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"GA Karpouzas","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjp.0705200","article-title":"Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury","volume":"139","author":"DG Souza","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1681\/ASN.2011030287","article-title":"Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis","volume":"23","author":"JL Gamboa","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"ref45","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"G Cice","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T23:26:14Z","timestamp":1540250774000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188720"}},"subtitle":[],"editor":[{"given":"Sadashiva S","family":"Karnik","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188720","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}